3'-PHENYL-4'-N-BENZYL-ADAMANTANE-2-SPIRO-5'-DELTA(2)-1',2',4'-OXADIAZOLINE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | HYlwNlPdAzq |
|---|---|
| InChI | InChI=1S/C24H26N2O/c1-3-7-17(8-4-1)16-26-23(20-9-5-2-6-10-20)25-27-24(26)21-12-18-11-19(14-21)15-22(24)13-18/h1-10,18-19,21-22H,11-16H2/t18-,19+,21-,22+,24- |
| InChIKey | ATVUDFKQJABNIV-XIJDFMEOSA-N |
| Mol Weight | 358.49 g/mol |
| Molecular Formula | C24H26N2O |
| Exact Mass | 358.204513 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-chloro-N-[3-(3-nitrophenyl)-1-oxa-2,4-diazaspiro[4.5]dec-2-en-4-yl]acetamide
4-(5-Benzo[1,3]dioxol-5-yl-4-butyl-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-benzoic acid methyl ester
2-chloro-N-[3-(3-nitrophenyl)-1-oxa-2,4-diazaspiro[4.4]non-2-en-4-yl]acetamide
N-[SPIRO-(2H-BENZO-[B]-PYRANO-2,2'-TRICYCLO-[3.3.1.1(3,7)]-DECAN-5-YL)]-MALONAMIDE
2-Hydroxy-N'-[(1Z,5S)-5-[3-(4-methoxyphenyl)-5-methyl-4,5-dihydro-1,2-oxazol-5-yl]-2-methylcyclohex-2-en-1-ylidene]benzohydrazide
(E)-3',5'-DIPHENYL-4'-HYDROXYSPIRO-(ADAMANTANE-2:5'-DELTA(2)-ISOXAZOLINE)
Ethyl 3-(2',5'-dihydroxybiphenyl-3'-yl)-6-oxocyclohex-1-ene-1-carboxylate
3-(3-bromophenyl)-N-[1-(2,6-dichlorobenzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-4,5-dihydro-5-isoxazolecarboxamide
(1S,4R,8S,11R)-3-Benzyl-6-isipropylidene-11-methyl-3-azatricyclo[6.2.1.0(4,11)]undecane
| Title | Journal or Book | Year |
|---|---|---|
| Temperature and Para-Substituent Effects on the Face Selectivity of 1,3-Dipolar Cycloaddition Reactions of Benzonitrile Oxides with 5-Substituted Adamantane-2-thiones, N-Benzyladamantyl-2-imines, and 2-Methyleneadamantanes | The Journal of Organic Chemistry | 1999 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.